These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2904830)

  • 1. Leucopenia in rheumatoid arthritis: relationship to gold or sulphasalazine therapy.
    Amos RS; Bax DE
    Br J Rheumatol; 1988 Dec; 27(6):465-8. PubMed ID: 2904830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leucopenia during sulphasalazine treatment for rheumatoid arthritis.
    Marabani M; Madhok R; Capell HA; Hunter JA
    Ann Rheum Dis; 1989 Jun; 48(6):505-7. PubMed ID: 2568110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA types in patients with rheumatoid arthritis developing leucopenia after both gold and sulphasalazine treatment.
    Bliddal H; Eiberg B; Helin P; Svejgaard A
    Ann Rheum Dis; 1989 Jul; 48(7):539-41. PubMed ID: 2570550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.
    Porter D; Madhok R; Hunter JA; Capell HA
    Ann Rheum Dis; 1992 Apr; 51(4):461-4. PubMed ID: 1350192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulphasalazine in rheumatoid arthritis: haematological problems and changes in haematological indices associated with therapy.
    Farr M; Tunn EJ; Symmons DP; Scott DG; Bacon PA
    Br J Rheumatol; 1989 Apr; 28(2):134-8. PubMed ID: 2565128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease.
    Capell HA; Pullar T; Hunter JA
    Drugs; 1986; 32 Suppl 1():44-8. PubMed ID: 2877852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.
    Amos RS; Pullar T; Bax DE; Situnayake D; Capell HA; McConkey B
    Br Med J (Clin Res Ed); 1986 Aug; 293(6544):420-3. PubMed ID: 2874863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold-induced leucopenia may predict a similar adverse reaction to sulphasalazine.
    Bliddal H; Eiberg B; Helin P
    Lancet; 1987 Feb; 1(8529):390. PubMed ID: 2880198
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences in long-term therapy of rheumatoid arthritis with sulfasalazine tablets].
    Amos RS
    Z Rheumatol; 1987; 46(2):76-8. PubMed ID: 2885988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutropenia in patients with inflammatory arthritis treated with sulphasalazine.
    Farr M; Symmons DP; Blake DR; Bacon PA
    Ann Rheum Dis; 1986 Sep; 45(9):761-4. PubMed ID: 2876683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
    Bax DE; Amos RS
    Ann Rheum Dis; 1985 Mar; 44(3):194-8. PubMed ID: 2858182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods.
    Situnayake RD; Grindulis KA; McConkey B
    Ann Rheum Dis; 1987 Mar; 46(3):177-83. PubMed ID: 2883939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind controlled study comparing sulphasalazine with placebo in rheumatoid factor (RF)-negative rheumatoid arthritis.
    Farr M; Waterhouse L; Johnson AE; Kitas GD; Jubb RW; Bacon PA
    Clin Rheumatol; 1995 Sep; 14(5):531-6. PubMed ID: 8549091
    [No Abstract]   [Full Text] [Related]  

  • 15. Profound leucopenia with Salazopyrin EN.
    Ridley MG; Cheung NT; Myles AB
    Br J Rheumatol; 1989 Aug; 28(4):364-5. PubMed ID: 2568149
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulphasalazine in rheumatoid arthritis.
    Bax DE; Amos RS; Situnayake D; McConkey B
    Lancet; 1985 Jun; 1(8443):1450. PubMed ID: 2861393
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis.
    van Riel PL; van Gestel AM; van de Putte LB
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():40-2. PubMed ID: 8535648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucopenia after gold and sulphasalazine treatment.
    Schmidt KL
    Ann Rheum Dis; 1990 Jun; 49(6):422. PubMed ID: 1974412
    [No Abstract]   [Full Text] [Related]  

  • 20. Leucopenia in adult Still's disease during treatment with azathioprine and sulphasalazine.
    Bliddal H; Helin P
    Clin Rheumatol; 1987 Jun; 6(2):244-50. PubMed ID: 2887331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.